Latest filing published 28 May 2026 for DuPont de Nemours, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ruby R. Chandy (board member) discloses dealings in 3 companies, chiefly DuPont de Nemours, Inc., Thermo Fisher Scientific Inc. and Ametek Inc/. We count 13 filings; the first trade dates from 4 November 2021 and the latest from 21 May 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 28 May 2026 with a share grant in DuPont de Nemours, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations